Editorial: the polygenic risk of cirrhosis development
- PMID: 33709398
- DOI: 10.1111/apt.16298
Editorial: the polygenic risk of cirrhosis development
Comment on
-
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis.Aliment Pharmacol Ther. 2021 Apr;53(7):830-843. doi: 10.1111/apt.16252. Epub 2021 Feb 10. Aliment Pharmacol Ther. 2021. PMID: 33565643
References
REFERENCES
-
- Buch S, Sharma A, Ryan E, et al. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis. Aliment Pharmacol Ther. 2021;53:830-843.
-
- Anstee QM, Darlay R, Cockell S, et al. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort. J Hepatol. 2020;73:505-515.
-
- Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461-1465.
-
- Buch S, Stickel F, Trépo E, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis. Nat Genet. 2015;47:1443-1448.
-
- Trépo E, Pradat P, Potthoff A, et al. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology. 2011;54:60-69.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical